Dr. Lynn Webster, M.D

NPI: 1164420246
Total Payments
$1.3M
2024 Payments
$5,025
Companies
18
Transactions
184

Payment Breakdown by Category

Research$1.0M (82.0%)
Consulting$153,455 (12.2%)
Other$48,235 (3.8%)
Travel$20,319 (1.6%)
Food & Beverage$4,628 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $1.0M 16 82.0%
Consulting Fee $153,455 23 12.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $28,835 19 2.3%
Travel and Lodging $20,319 61 1.6%
Honoraria $19,400 7 1.5%
Food and Beverage $4,628 58 0.4%

Payments by Type

Research
$1.0M
16 transactions
General
$226,637
168 transactions

Top Paying Companies

Company Total Records Latest Year
BioDelivery Sciences International, Inc. $1.1M 45 $0 (2021)
Mallinckrodt LLC $74,897 15 $0 (2019)
PFIZER INC. $25,962 7 $0 (2019)
Collegium Pharmaceutical, Inc. $25,327 20 $0 (2023)
Shionogi Inc $24,978 53 $0 (2023)
Daiichi Sankyo Inc. $12,360 7 $0 (2019)
INSYS Therapeutics Inc $10,819 7 $0 (2018)
Indivior Inc. $9,777 4 $0 (2017)
Pernix Therapeutics Holdings, Inc. $6,987 5 $0 (2018)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $3,597 6 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,025 2 Orion Corporation ($2,625)
2023 $25,587 12 Collegium Pharmaceutical, Inc. ($24,027)
2022 $1,236 8 Collegium Pharmaceutical, Inc. ($1,236)
2021 $7,927 5 RedHill Biopharma Inc. ($3,120)
2020 $6,362 16 Shionogi Inc ($3,348)
2019 $1.1M 73 BioDelivery Sciences International, Inc. ($1.0M)
2018 $51,913 52 Mallinckrodt LLC ($23,389)
2017 $33,591 16 PFIZER INC. ($13,676)

All Payment Transactions

184 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
03/07/2024 Orion Corporation Consulting Fee Cash or cash equivalent $2,625.00 General
01/23/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Honoraria Cash or cash equivalent $2,400.00 General
Category: Analgesic
11/20/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Consulting Fee Cash or cash equivalent $4,500.00 General
Category: Opioid Analgesic
09/21/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $22.61 General
Category: Opioid Analgesic
09/21/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $19.66 General
Category: Opioid Analgesic
09/20/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $189.00 General
Category: Opioid Analgesic
09/19/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $189.00 General
Category: Opioid Analgesic
09/12/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Consulting Fee Cash or cash equivalent $3,125.00 General
Category: Opioid Analgesic
09/10/2023 Collegium Pharmaceutical, Inc. BELBUCA (Drug), XTAMPZA Consulting Fee Cash or cash equivalent $3,500.00 General
Category: Opioid Analgesic
09/08/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug), Xtampza Food and Beverage In-kind items and services $97.02 General
Category: Opioid Analgesic
08/17/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Consulting Fee Cash or cash equivalent $4,750.00 General
Category: Opioid Analgesic
02/09/2023 Shionogi Inc Consulting Fee Cash or cash equivalent $1,560.00 General
01/10/2023 Collegium Pharmaceutical, Inc. BELBUCA (Drug), XTAMPZA, NUCYNTA Consulting Fee Cash or cash equivalent $7,430.00 General
Category: Opioid Analgesic
01/10/2023 Collegium Pharmaceutical, Inc. BELBUCA (Drug), XTAMPZA, NUCYNTA Travel and Lodging Cash or cash equivalent $204.34 General
Category: Opioid Analgesic
12/03/2022 Collegium Pharmaceutical, Inc. Food and Beverage In-kind items and services $62.08 General
12/03/2022 Collegium Pharmaceutical, Inc. Food and Beverage In-kind items and services $48.29 General
12/03/2022 Collegium Pharmaceutical, Inc. Food and Beverage In-kind items and services $29.65 General
12/03/2022 Collegium Pharmaceutical, Inc. Travel and Lodging In-kind items and services $13.25 General
12/02/2022 Collegium Pharmaceutical, Inc. Travel and Lodging In-kind items and services $600.20 General
12/02/2022 Collegium Pharmaceutical, Inc. Travel and Lodging In-kind items and services $302.63 General
12/02/2022 Collegium Pharmaceutical, Inc. Food and Beverage In-kind items and services $125.77 General
09/09/2022 Collegium Pharmaceutical, Inc. ELYXYB - celecoxib (Drug) Food and Beverage Cash or cash equivalent $54.41 General
Category: Migraine
10/01/2021 Shionogi Inc Symproic (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,779.72 General
Category: Gastroenterology
10/01/2021 Shionogi Inc Symproic (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $950.70 General
Category: Gastroenterology
09/08/2021 BioDelivery Sciences International, Inc. BELBUCA (Drug), SYMPROIC Food and Beverage In-kind items and services $76.42 General
Category: Chronic Pain

Research Studies & Clinical Trials

Study Name Company Amount Records
SINGLE DOSE CROSSOVER STUDY TO COMPARE THE RESPIRATORY DRIVE AFTER ADMINISTRATION OF BELBUCA, OXYCODONE AND PLACEBO. BIODELIVERY SCIENCES INTERNATIONAL, INC. $1.0M 11
Health Economics and Outcomes Research HEOR Regeneron Pharmaceuticals, Inc. $1,658 5

About Dr. Lynn Webster, M.D

Dr. Lynn Webster, M.D is a Pain Medicine healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164420246.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lynn Webster, M.D has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $5,025 received in 2024. These payments were reported across 184 transactions from 18 companies. The most common payment nature is "" ($1.0M).

Practice Information

  • Specialty Pain Medicine
  • Other Specialties Pain Medicine
  • Location Salt Lake City, UT
  • Active Since 07/12/2005
  • Last Updated 12/10/2009
  • Taxonomy Code 207LP2900X
  • Entity Type Individual
  • NPI Number 1164420246

Products in Payments

  • BELBUCA (Drug) $1.1M
  • TROXYCA ER (Drug) $21,762
  • Symproic (Drug) $20,418
  • Belbuca (Drug) $12,892
  • SUBOXONE (Drug) $9,777
  • ZOHYDRO ER (Drug) $6,987
  • EMBEDA (Drug) $4,200
  • LUCEMYRA (Drug) $3,597
  • Movantik (Drug) $3,134
  • Buprenorphine (Drug) $2,719
  • ZTLido (Drug) $2,400
  • Evzio (Drug) $72.01
  • ARYMO ER (Drug) $71.96
  • Xtampza ER (Drug) $64.44
  • ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $62.87
  • ELYXYB - celecoxib (Drug) $54.41
  • RELISTOR (Drug) $15.25

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pain Medicine Doctors in Salt Lake City